RZLT (Rezolute, Inc.) Utang jangka cendhak marang modal

Logo korporat perusahaan Rezolute, Inc. (RZLT)

The daily price action for Rezolute, Inc. (RZLT) on the GURU.Markets platform is recorded at 0.01. Rezolute, Inc. (RZLT) is implementing AI algorithms and robotics to accelerate the discovery of therapeutic agents. The business focuses on developing drugs for orphan diseases, leveraging the global scaling of patents. High scientific authority and positive investor forecasts confirm the brand's significant potential.

Rasio tanggungan utang jangka cendhak marang modal: Rezolute Corp (RZLT) kanggo 04.07.2022 - 30.10.2026
Produk merek Rezolute Inc

Investors must determine whether short-term liquidity risks outweigh the asset growth potential of Rezolute, Inc. (RZLT). When analyzing the current short-term debt-to-equity chart, one should evaluate the proportion of liabilities due within one year relative to equity, which, given the full control of partner manufacturing capacities, confirms financial stability during the development of new drug candidates.

Pesaing Rezolute, Inc.

Utang jangka cendhak marang modal ASND|MDGL (Madrigal Corp) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal CORT (Corcept Therapeutics)|Utang jangka cendhak marang modal rhythmtx.com RYTM|AKRO - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal MTSR (Metsera, Inc.)|MoonLake Pharma (MLTX) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Crinetics Corp|NAMS (NewAmsterdam Pharma) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal soleno.life|Rasio utang jangka cendhak marang ekuitas FOLD (Amicus Therapeutics, Inc.)|ETNB (89bio Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Agios Pharmaceuticals Inc AGIO|GPCR - Rasio utang jangka cendhak marang ekuitas|MiMedx Group, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal lexpharma.com|MBX (MBX Biosciences) - Rasio utang jangka cendhak marang ekuitas|ALT: Rasio silihan jangka cendhak marang modal|AARD (Aardvark Therapeutics Corp) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Sagimet Biosciences Inc|Utang jangka cendhak marang modal BIOA|Utang jangka cendhak marang ekuitas BMEA (biomeafusion.com)|Utang jangka cendhak marang ekuitas Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. (GUTS) - Kewajiban jangka cendhak marang modal|VTVT - Utang jangka cendhak marang ekuitas|ATPC: Utang jangka cendhak marang ekuitas|PLUR: Utang jangka cendhak marang modal|SYBX - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Lipocine|Matinas BioPharma Holdings Inc. (MTNB) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Spruce Biosciences (SPRB)|Rasio utang jangka cendhak marang ekuitas Galecto Corporation GLTO|Utang jangka cendhak marang ekuitas Carmell Corporation CTCX|Rasio tanggungan utang jangka cendhak marang modal LUMO|Organovo - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Radius Recycling Inc.